While cases of syphilis in Europe were first recorded over 500 years ago, no vaccine candidates have ever advanced to human clinical trials. A new international, multi-university center led by the University of Connecticut School of Medicine and the Connecticut Children’s Medical Center aims to change that.
The University of Connecticut will receive up to $11 million over five years from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) to develop a vaccine for this centuries-old disease. more